Clinical Trial Update: Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AMT2003 in patients with advanced hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AMT2003

Snippet

Sponsor: Auron Healthcare GmbH | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED